nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP1—hematologic cancer	0.326	0.705	CbGaD
Lucanthone—TOP2A—hematologic cancer	0.136	0.295	CbGaD
Lucanthone—TOP1—Irinotecan—hematologic cancer	0.115	0.271	CbGbCtD
Lucanthone—TOP2A—Idarubicin—hematologic cancer	0.0868	0.205	CbGbCtD
Lucanthone—TOP2A—Daunorubicin—hematologic cancer	0.0614	0.145	CbGbCtD
Lucanthone—TOP2A—Teniposide—hematologic cancer	0.0534	0.126	CbGbCtD
Lucanthone—TOP2A—Mitoxantrone—hematologic cancer	0.0373	0.0881	CbGbCtD
Lucanthone—TOP2A—Epirubicin—hematologic cancer	0.0302	0.0713	CbGbCtD
Lucanthone—TOP2A—Etoposide—hematologic cancer	0.0235	0.0556	CbGbCtD
Lucanthone—TOP2A—Doxorubicin—hematologic cancer	0.0161	0.0379	CbGbCtD
Lucanthone—APEX1—hematopoietic system—hematologic cancer	0.00382	0.125	CbGeAlD
Lucanthone—APEX1—gonad—hematologic cancer	0.0029	0.0953	CbGeAlD
Lucanthone—APEX1—blood—hematologic cancer	0.00253	0.083	CbGeAlD
Lucanthone—APEX1—bone marrow—hematologic cancer	0.00245	0.0803	CbGeAlD
Lucanthone—APEX1—lung—hematologic cancer	0.00222	0.0728	CbGeAlD
Lucanthone—APEX1—testis—hematologic cancer	0.00209	0.0687	CbGeAlD
Lucanthone—TOP1—blood—hematologic cancer	0.00177	0.0581	CbGeAlD
Lucanthone—TOP1—bone marrow—hematologic cancer	0.00171	0.0562	CbGeAlD
Lucanthone—TOP1—lung—hematologic cancer	0.00155	0.0509	CbGeAlD
Lucanthone—APEX1—lymph node—hematologic cancer	0.00152	0.0498	CbGeAlD
Lucanthone—TOP1—testis—hematologic cancer	0.00146	0.0481	CbGeAlD
Lucanthone—TOP2A—blood—hematologic cancer	0.00126	0.0414	CbGeAlD
Lucanthone—TOP2A—bone marrow—hematologic cancer	0.00122	0.04	CbGeAlD
Lucanthone—TOP2A—lung—hematologic cancer	0.0011	0.0362	CbGeAlD
Lucanthone—TOP1—lymph node—hematologic cancer	0.00106	0.0348	CbGeAlD
Lucanthone—TOP2A—testis—hematologic cancer	0.00104	0.0342	CbGeAlD
Lucanthone—TOP2A—lymph node—hematologic cancer	0.000755	0.0248	CbGeAlD
Lucanthone—APEX1—Doxorubicin—Daunorubicin—hematologic cancer	0.000351	0.103	CbGdCrCtD
Lucanthone—APEX1—Epirubicin—Daunorubicin—hematologic cancer	0.000351	0.103	CbGdCrCtD
Lucanthone—APEX1—Doxorubicin—Idarubicin—hematologic cancer	0.000266	0.0779	CbGdCrCtD
Lucanthone—APEX1—Epirubicin—Idarubicin—hematologic cancer	0.000266	0.0779	CbGdCrCtD
Lucanthone—TOP2A—Nilotinib—Imatinib—hematologic cancer	0.000151	0.0443	CbGdCrCtD
Lucanthone—APEX1—Doxorubicin—Epirubicin—hematologic cancer	0.000122	0.0358	CbGdCrCtD
Lucanthone—APEX1—Epirubicin—Doxorubicin—hematologic cancer	0.000113	0.0331	CbGdCrCtD
Lucanthone—Procainamide—SLC22A1—hematologic cancer	9.5e-05	0.607	CrCbGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	9.46e-05	0.00118	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1B—hematologic cancer	9.35e-05	0.00117	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	9.32e-05	0.00116	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IFNG—hematologic cancer	9.3e-05	0.00116	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—hematologic cancer	9.21e-05	0.00115	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDKN1A—hematologic cancer	9.2e-05	0.00115	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—NUP98—hematologic cancer	9.11e-05	0.00114	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—JUND—hematologic cancer	9.1e-05	0.00114	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—H3F3B—hematologic cancer	9.04e-05	0.00113	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—FOXM1—hematologic cancer	9.04e-05	0.00113	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK6—hematologic cancer	8.99e-05	0.00112	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	8.98e-05	0.00112	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—hematologic cancer	8.94e-05	0.00112	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—NUP214—hematologic cancer	8.78e-05	0.0011	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—PIK3CA—hematologic cancer	8.74e-05	0.00109	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—hematologic cancer	8.71e-05	0.00109	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—NPM1—hematologic cancer	8.71e-05	0.00109	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1A—hematologic cancer	8.63e-05	0.00108	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND3—hematologic cancer	8.55e-05	0.00107	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	8.51e-05	0.00106	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	8.51e-05	0.00106	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDKN1B—hematologic cancer	8.45e-05	0.00105	CbGpPWpGaD
Lucanthone—TOP2A—Topotecan—Irinotecan—hematologic cancer	8.4e-05	0.0246	CbGdCrCtD
Lucanthone—TOP2A—Etoposide—Teniposide—hematologic cancer	8.35e-05	0.0244	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	8.34e-05	0.00104	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL1B—hematologic cancer	8.3e-05	0.00104	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CASP3—hematologic cancer	8.28e-05	0.00103	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL2—hematologic cancer	8.27e-05	0.00103	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1B—hematologic cancer	8.17e-05	0.00102	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—CST3—hematologic cancer	8.17e-05	0.00102	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—NUP98—hematologic cancer	8.14e-05	0.00102	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	8.12e-05	0.00101	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	8.1e-05	0.00101	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—HRAS—hematologic cancer	8.08e-05	0.00101	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCND1—hematologic cancer	8.06e-05	0.00101	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	8.01e-05	0.001	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	7.85e-05	0.00098	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—NUP214—hematologic cancer	7.85e-05	0.00098	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	7.83e-05	0.000978	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCND1—hematologic cancer	7.8e-05	0.000973	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK2—hematologic cancer	7.79e-05	0.000973	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—JUN—hematologic cancer	7.78e-05	0.000971	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—SMC1A—hematologic cancer	7.74e-05	0.000967	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND2—hematologic cancer	7.73e-05	0.000965	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PML—hematologic cancer	7.69e-05	0.00096	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TOP2A—hematologic cancer	7.67e-05	0.000957	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	7.66e-05	0.000957	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RAD1—hematologic cancer	7.6e-05	0.000948	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—H3F3A—hematologic cancer	7.59e-05	0.000948	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1A—hematologic cancer	7.54e-05	0.000942	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—PTEN—hematologic cancer	7.52e-05	0.000939	CbGpPWpGaD
Lucanthone—TOP2A—Vindesine—Vinorelbine—hematologic cancer	7.51e-05	0.022	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	7.47e-05	0.000933	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—hematologic cancer	7.37e-05	0.00092	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—MAPK8—hematologic cancer	7.36e-05	0.000919	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	7.29e-05	0.00091	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	7.27e-05	0.000907	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MLH1—hematologic cancer	7.23e-05	0.000903	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EP300—hematologic cancer	7.17e-05	0.000895	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—hematologic cancer	7.15e-05	0.000893	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—AKT1—hematologic cancer	7.14e-05	0.000891	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK6—hematologic cancer	7.13e-05	0.00089	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	7.08e-05	0.000883	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TERF2—hematologic cancer	7.01e-05	0.000875	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	6.96e-05	0.000868	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2B—hematologic cancer	6.93e-05	0.000865	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RAD21—hematologic cancer	6.93e-05	0.000865	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—SMC1A—hematologic cancer	6.92e-05	0.000864	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TOP2A—hematologic cancer	6.85e-05	0.000856	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—H3F3A—hematologic cancer	6.79e-05	0.000847	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	6.69e-05	0.000836	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EZH2—hematologic cancer	6.68e-05	0.000834	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MAPK3—hematologic cancer	6.65e-05	0.00083	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	6.51e-05	0.000813	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	6.49e-05	0.000811	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—hematologic cancer	6.46e-05	0.000807	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TGFB1—hematologic cancer	6.45e-05	0.000805	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—SMC3—hematologic cancer	6.44e-05	0.000804	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RB1—hematologic cancer	6.4e-05	0.0008	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	6.39e-05	0.000798	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK6—hematologic cancer	6.37e-05	0.000796	CbGpPWpGaD
Lucanthone—TOP2A—Podofilox—Teniposide—hematologic cancer	6.37e-05	0.0186	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	6.33e-05	0.000791	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—HDAC2—hematologic cancer	6.31e-05	0.000787	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—hematologic cancer	6.25e-05	0.000781	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RAD21—hematologic cancer	6.19e-05	0.000773	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYBL2—hematologic cancer	6.17e-05	0.000771	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND2—hematologic cancer	6.13e-05	0.000765	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	6.06e-05	0.000757	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TNF—hematologic cancer	6.02e-05	0.000752	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	6.02e-05	0.000751	CbGpPWpGaD
Lucanthone—TOP2A—Vindesine—Vinblastine—hematologic cancer	6e-05	0.0176	CbGdCrCtD
Lucanthone—TOP2A—Vindesine—Vincristine—hematologic cancer	6e-05	0.0176	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	5.89e-05	0.000735	CbGpPWpGaD
Lucanthone—TOP2A—Floxuridine—Pentostatin—hematologic cancer	5.79e-05	0.0169	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—SMC3—hematologic cancer	5.76e-05	0.000719	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—HSP90AA1—hematologic cancer	5.72e-05	0.000714	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	5.7e-05	0.000711	CbGpPWpGaD
Lucanthone—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	5.67e-05	0.0166	CbGdCrCtD
Lucanthone—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	5.67e-05	0.0166	CbGdCrCtD
Lucanthone—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	5.67e-05	0.0166	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	5.53e-05	0.00069	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—POT1—hematologic cancer	5.52e-05	0.000689	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYBL2—hematologic cancer	5.52e-05	0.000689	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	5.51e-05	0.000688	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	5.5e-05	0.000686	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	5.49e-05	0.000686	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK2—hematologic cancer	5.48e-05	0.000685	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND2—hematologic cancer	5.48e-05	0.000684	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—hematologic cancer	5.46e-05	0.000682	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	5.35e-05	0.000668	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—hematologic cancer	5.31e-05	0.000663	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	5.29e-05	0.000661	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	5.29e-05	0.000661	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	5.25e-05	0.000655	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK4—hematologic cancer	5.18e-05	0.000647	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—hematologic cancer	5.13e-05	0.000641	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—ATR—hematologic cancer	5.13e-05	0.000641	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—hematologic cancer	5.13e-05	0.00064	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—STAG2—hematologic cancer	5.11e-05	0.000639	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—hematologic cancer	4.99e-05	0.000622	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	4.92e-05	0.000614	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2B—hematologic cancer	4.91e-05	0.000613	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—IL6—hematologic cancer	4.86e-05	0.000607	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	4.85e-05	0.000606	CbGpPWpGaD
Lucanthone—TOP2A—Menadione—Thalidomide—hematologic cancer	4.82e-05	0.0141	CbGdCrCtD
Lucanthone—TOP2A—Circadian rythm related genes—NCOR1—hematologic cancer	4.78e-05	0.000597	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	4.77e-05	0.000595	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—hematologic cancer	4.76e-05	0.000594	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—BIRC5—hematologic cancer	4.74e-05	0.000592	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—IL6—hematologic cancer	4.7e-05	0.000587	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—FOXM1—hematologic cancer	4.68e-05	0.000584	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—H3F3B—hematologic cancer	4.68e-05	0.000584	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	4.63e-05	0.000578	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—hematologic cancer	4.6e-05	0.000574	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—STAG2—hematologic cancer	4.57e-05	0.000571	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PRKCG—hematologic cancer	4.56e-05	0.000569	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.52e-05	0.000564	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RB1—hematologic cancer	4.51e-05	0.000563	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	4.46e-05	0.000557	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND3—hematologic cancer	4.42e-05	0.000552	CbGpPWpGaD
Lucanthone—TOP2A—Cladribine—Pentostatin—hematologic cancer	4.38e-05	0.0128	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK2—hematologic cancer	4.35e-05	0.000543	CbGpPWpGaD
Lucanthone—TOP2A—Epirubicin—Idarubicin—hematologic cancer	4.3e-05	0.0126	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	4.3e-05	0.0126	CbGdCrCtD
Lucanthone—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	4.3e-05	0.0126	CbGdCrCtD
Lucanthone—TOP2A—Circadian rythm related genes—FAS—hematologic cancer	4.28e-05	0.000535	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BIRC5—hematologic cancer	4.24e-05	0.000529	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—NUP98—hematologic cancer	4.21e-05	0.000526	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—FOXM1—hematologic cancer	4.18e-05	0.000522	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—H3F3B—hematologic cancer	4.18e-05	0.000522	CbGpPWpGaD
Lucanthone—Amiodarone—ABCB1—hematologic cancer	4.17e-05	0.267	CrCbGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	4.15e-05	0.000519	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK4—hematologic cancer	4.11e-05	0.000513	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TERT—hematologic cancer	4.11e-05	0.000513	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—NUP214—hematologic cancer	4.06e-05	0.000507	CbGpPWpGaD
Lucanthone—TOP2A—Vincristine—Vinorelbine—hematologic cancer	4.05e-05	0.0119	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—NPM1—hematologic cancer	4.03e-05	0.000503	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	3.99e-05	0.000498	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—hematologic cancer	3.96e-05	0.000495	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND3—hematologic cancer	3.96e-05	0.000494	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	3.94e-05	0.000492	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	3.93e-05	0.00049	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	3.91e-05	0.000488	CbGpPWpGaD
Lucanthone—TOP2A—Cladribine—Clofarabine—hematologic cancer	3.91e-05	0.0114	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle—CDK2—hematologic cancer	3.89e-05	0.000485	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	3.82e-05	0.000476	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	3.82e-05	0.000476	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	3.82e-05	0.000476	CbGpPWpGaD
Lucanthone—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	3.79e-05	0.0111	CbGdCrCtD
Lucanthone—TOP2A—Vinorelbine—Vincristine—hematologic cancer	3.79e-05	0.0111	CbGdCrCtD
Lucanthone—TOP2A—Podofilox—Etoposide—hematologic cancer	3.79e-05	0.0111	CbGdCrCtD
Lucanthone—TOP2A—Teniposide—Etoposide—hematologic cancer	3.79e-05	0.0111	CbGdCrCtD
Lucanthone—TOP2A—Circadian rythm related genes—CDK4—hematologic cancer	3.77e-05	0.000471	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—NUP98—hematologic cancer	3.77e-05	0.00047	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—ATM—hematologic cancer	3.69e-05	0.000461	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK4—hematologic cancer	3.68e-05	0.000459	CbGpPWpGaD
Lucanthone—TOP2A—Cladribine—Nelarabine—hematologic cancer	3.67e-05	0.0107	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—NUP214—hematologic cancer	3.63e-05	0.000453	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—SMC1A—hematologic cancer	3.58e-05	0.000447	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RB1—hematologic cancer	3.57e-05	0.000446	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	3.52e-05	0.000439	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—H3F3A—hematologic cancer	3.51e-05	0.000438	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1B—hematologic cancer	3.51e-05	0.000438	CbGpPWpGaD
Lucanthone—TOP2A—Floxuridine—Cladribine—hematologic cancer	3.48e-05	0.0102	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	3.44e-05	0.00043	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	3.43e-05	0.000428	CbGpPWpGaD
Lucanthone—TOP2A—Clofarabine—Nelarabine—hematologic cancer	3.39e-05	0.00993	CbGdCrCtD
Lucanthone—TOP2A—Circadian rythm related genes—CREB1—hematologic cancer	3.38e-05	0.000422	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND1—hematologic cancer	3.35e-05	0.000418	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MLH1—hematologic cancer	3.34e-05	0.000417	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK6—hematologic cancer	3.3e-05	0.000411	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	3.27e-05	0.000408	CbGpPWpGaD
Lucanthone—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	3.26e-05	0.00953	CbGdCrCtD
Lucanthone—TOP2A—Vincristine—Vinblastine—hematologic cancer	3.24e-05	0.00948	CbGdCrCtD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	3.24e-05	0.000404	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—SMC1A—hematologic cancer	3.2e-05	0.0004	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RB1—hematologic cancer	3.2e-05	0.000399	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	3.14e-05	0.000392	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—H3F3A—hematologic cancer	3.14e-05	0.000392	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	3.13e-05	0.000391	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	3.11e-05	0.000388	CbGpPWpGaD
Lucanthone—TOP2A—Cytarabine—Clofarabine—hematologic cancer	3.07e-05	0.00899	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	2.96e-05	0.000369	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	2.95e-05	0.000369	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK6—hematologic cancer	2.95e-05	0.000368	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	2.91e-05	0.000363	CbGpPWpGaD
Lucanthone—TOP2A—Cytarabine—Nelarabine—hematologic cancer	2.89e-05	0.00845	CbGdCrCtD
Lucanthone—TOP2A—Cladribine—Fludarabine—hematologic cancer	2.87e-05	0.00839	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND2—hematologic cancer	2.83e-05	0.000354	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2A—hematologic cancer	2.81e-05	0.000351	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	2.78e-05	0.000347	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MDM2—hematologic cancer	2.72e-05	0.00034	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—hematologic cancer	2.68e-05	0.000335	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	2.66e-05	0.000332	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND1—hematologic cancer	2.65e-05	0.000331	CbGpPWpGaD
Lucanthone—TOP2A—Clofarabine—Fludarabine—hematologic cancer	2.65e-05	0.00775	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—HSP90AA1—hematologic cancer	2.64e-05	0.00033	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	2.61e-05	0.000325	CbGpPWpGaD
Lucanthone—TOP2A—Vinblastine—Vincristine—hematologic cancer	2.6e-05	0.00762	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	2.57e-05	0.000321	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	2.54e-05	0.000317	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	2.54e-05	0.000317	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND2—hematologic cancer	2.53e-05	0.000316	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	2.53e-05	0.000316	CbGpPWpGaD
Lucanthone—TOP2A—Clofarabine—Cytarabine—hematologic cancer	2.5e-05	0.00732	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle—CDKN1B—hematologic cancer	2.49e-05	0.000311	CbGpPWpGaD
Lucanthone—TOP2A—Azacitidine—Pentostatin—hematologic cancer	2.47e-05	0.00723	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	2.45e-05	0.000306	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	2.45e-05	0.000306	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—EP300—hematologic cancer	2.44e-05	0.000305	CbGpPWpGaD
Lucanthone—TOP2A—Clofarabine—Cladribine—hematologic cancer	2.44e-05	0.00714	CbGdCrCtD
Lucanthone—TOP2A—Circadian rythm related genes—JUN—hematologic cancer	2.43e-05	0.000303	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.39e-05	0.000299	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND1—hematologic cancer	2.37e-05	0.000296	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—PTEN—hematologic cancer	2.35e-05	0.000293	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.33e-05	0.000291	CbGpPWpGaD
Lucanthone—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	2.32e-05	0.00678	CbGdCrCtD
Lucanthone—TOP2A—Circadian rythm related genes—MAPK8—hematologic cancer	2.3e-05	0.000287	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1A—hematologic cancer	2.3e-05	0.000287	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2B—hematologic cancer	2.27e-05	0.000284	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	2.27e-05	0.000283	CbGpPWpGaD
Lucanthone—TOP2A—Cytarabine—Fludarabine—hematologic cancer	2.25e-05	0.0066	CbGdCrCtD
Lucanthone—TOP2A—Circadian rythm related genes—EP300—hematologic cancer	2.24e-05	0.00028	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.21e-05	0.000276	CbGpPWpGaD
Lucanthone—TOP2A—Azacitidine—Clofarabine—hematologic cancer	2.2e-05	0.00644	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle, Mitotic—BIRC5—hematologic cancer	2.19e-05	0.000274	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MAPK3—hematologic cancer	2.19e-05	0.000273	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—EP300—hematologic cancer	2.18e-05	0.000273	CbGpPWpGaD
Lucanthone—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	2.13e-05	0.00623	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—hematologic cancer	2.13e-05	0.000266	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.09e-05	0.000261	CbGpPWpGaD
Lucanthone—TOP2A—Azacitidine—Nelarabine—hematologic cancer	2.07e-05	0.00606	CbGdCrCtD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.03e-05	0.000254	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.03e-05	0.000253	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK2—hematologic cancer	2.01e-05	0.000251	CbGpPWpGaD
Lucanthone—Flurazepam—ABCB1—hematologic cancer	1.98e-05	0.126	CrCbGaD
Lucanthone—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	1.97e-05	0.00578	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	1.97e-05	0.00578	CbGdCrCtD
Lucanthone—TOP2A—Idarubicin—Epirubicin—hematologic cancer	1.97e-05	0.00578	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—BIRC5—hematologic cancer	1.96e-05	0.000245	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MAPK3—hematologic cancer	1.96e-05	0.000244	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—hematologic cancer	1.9e-05	0.000238	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK4—hematologic cancer	1.9e-05	0.000237	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TERT—hematologic cancer	1.9e-05	0.000237	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.89e-05	0.000237	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.88e-05	0.000235	CbGpPWpGaD
Lucanthone—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	1.83e-05	0.00535	CbGdCrCtD
Lucanthone—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	1.83e-05	0.00535	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	1.83e-05	0.00535	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—CDK2—hematologic cancer	1.8e-05	0.000225	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.73e-05	0.000216	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—ATM—hematologic cancer	1.71e-05	0.000213	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK4—hematologic cancer	1.7e-05	0.000212	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.67e-05	0.000209	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RB1—hematologic cancer	1.65e-05	0.000206	CbGpPWpGaD
Lucanthone—TOP2A—Azacitidine—Fludarabine—hematologic cancer	1.62e-05	0.00473	CbGdCrCtD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—hematologic cancer	1.6e-05	0.0002	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—hematologic cancer	1.56e-05	0.000195	CbGpPWpGaD
Lucanthone—TOP2A—Azacitidine—Cytarabine—hematologic cancer	1.53e-05	0.00447	CbGdCrCtD
Lucanthone—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	1.53e-05	0.00447	CbGdCrCtD
Lucanthone—TOP2A—Azacitidine—Cladribine—hematologic cancer	1.49e-05	0.00435	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—RB1—hematologic cancer	1.48e-05	0.000185	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—IL6—hematologic cancer	1.47e-05	0.000183	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	1.45e-05	0.000181	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.41e-05	0.000176	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2A—hematologic cancer	1.3e-05	0.000162	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	1.29e-05	0.000161	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MDM2—hematologic cancer	1.26e-05	0.000157	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND1—hematologic cancer	1.23e-05	0.000153	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	1.19e-05	0.000148	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1B—hematologic cancer	1.15e-05	0.000144	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—EP300—hematologic cancer	1.13e-05	0.000141	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND1—hematologic cancer	1.1e-05	0.000137	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	1.06e-05	0.000133	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	1.01e-05	0.000126	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—EP300—hematologic cancer	1.01e-05	0.000126	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	9.85e-06	0.000123	CbGpPWpGaD
Lucanthone—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	9.11e-06	0.00267	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—MAPK3—hematologic cancer	9.05e-06	0.000113	CbGpPWpGaD
Lucanthone—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	8.89e-06	0.0026	CbGdCrCtD
Lucanthone—TOP2A—Cell Cycle—MYC—hematologic cancer	8.8e-06	0.00011	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—hematologic cancer	7.23e-06	9.03e-05	CbGpPWpGaD
